Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
07/2010
07/22/2010WO2009080198A8 Fused cynopryridines and the use thereof
07/22/2010US20100184984 Method of preparing 4-amino-1h-imidazo (4,5-c) quinolines and acid addition salts thereof
07/22/2010US20100184983 Aqueous synthesis of perylene pigments
07/22/2010US20100184980 Process for Preparing 5-Fluoro-1H-Pyrazolo [3,4-b] Pyridin-3-amine and Derivatives Thereof
07/22/2010US20100184800 Compounds for the Treatment of Hepatitis C
07/22/2010US20100184799 Oxadiazole beta carboline derivatives as antidiabetic compounds
07/22/2010US20100184795 Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same
07/22/2010US20100184790 Pyrrolo[2,3-b]pyridine compounds, azaindole compounds used for synthesizing said pyrrolo[2,3-b]pyridine compounds, methods for the production thereof, and uses thereof
07/22/2010US20100184775 Organic compounds
07/22/2010US20100184761 6-PHENYL-1H-IMIDAZO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES
07/22/2010US20100184758 Beta carboline derivatives as antidiabetic compounds
07/22/2010US20100184754 Quinolinone derivatives
07/22/2010US20100184751 Heterocyclic compounds for the treatment of tuberculosis
07/22/2010US20100184598 4-aza indole derivatives and their use as fungicides
07/22/2010US20100184074 Universal nucleotides for nucleic acid analysis
07/22/2010US20100183712 Acylated indanyl amines and their use as pharmaceuticals
07/22/2010US20100183552 1-[2-amino-3-(substituted alkyl)-3h-benzimidazolylmethyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogs
07/22/2010CA2749348A1 6-phenyl-ih-imidazo [4, 5-c] pyridine-4-carbonitrile derivatives as cathepsin s and/or cathepsin k inhibitors
07/22/2010CA2749114A1 Heteroatom-containing cyclic compound
07/22/2010CA2748831A1 Oxadiazole beta carboline derivatives as antidiabetic compounds
07/22/2010CA2747752A1 Novel benzenesulfonamides as calcium channel blockers
07/21/2010EP2208729A1 Oxazolidinone derivative having 7-membered hetero ring
07/21/2010EP2099787B1 Aminopyrimidines useful as inhibitors of protein kinases
07/21/2010EP1940840B1 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
07/21/2010EP1636216B1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
07/21/2010EP1399445B9 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
07/21/2010CN1993446B Red electroluminescent compounds and organic electroluminescent device using the same
07/21/2010CN1960977B Quinazoline derivative
07/21/2010CN101784547A Pyrazoloquinoline and pyrazolonaphthyridine derivatives as gaba alpha ligands
07/21/2010CN101784546A Tricyclic heterocyclic compounds as gaba a modulators
07/21/2010CN101784529A Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors
07/21/2010CN101784522A proton acceptor iminium/carbocation-type coupling agents
07/21/2010CN101784516A Dipeptide analogs as coagulation factor inhibitors
07/21/2010CN101784276A Use of compounds for preparing anti-tuberculosis agents
07/21/2010CN101781312A Method for synthesizing derivatives of quinoline or indole
07/21/2010CN101781302A Adduct generated from phosphodiesterase inhibitor and isoflavone and application thereof
07/21/2010CN101781299A One-pot synthesis method for key intermediate of carbostyril medicaments
07/21/2010CN101781298A Method for preparing 5-cyano-7-azaindole
07/21/2010CN101781297A Preparation method of pyrazole-chinoline [5, 1-a] skeleton compound
07/21/2010CN101369633B Pyran derivative
07/20/2010US7759486 2,4,5-Trisubstituted pyrimidine compounds
07/20/2010US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain
07/20/2010US7759388 Phenylalanine derivatives
07/20/2010US7759373 nitrogen-containing 5-membered heterocyclic compound
07/20/2010US7759372 benzimidazole derivatives having antiviral activities, used optionally in combination with a polymerase inhibitor and/or a protease inhibitor
07/20/2010US7759367 Pharmaceutical compositions and their uses
07/20/2010US7759362 1-cyclopropyl-8-difluoromethoxyl-7-[(1S,6S)-2,8-diazabicyclo[4,3,0]nonane-8-yl]-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride, having potent antibacterial activity against broad-spectrum pathogenic bacteria, with favorable pharmacokinetics and very low toxicity
07/20/2010US7759333 pentaazacycle manganese complexes, as mimetics for oxidoreductase enzymes,used for the treatment of age-related macular degeneration, diabetic retinopathy and edema; vision defects
07/20/2010CA2532049C Isethionate salt of a selective cdk4 inhibitor
07/20/2010CA2486399C Calcium receptor modulating agents
07/20/2010CA2485323C Process for preparing 6-o-monoesters of castanospermine
07/20/2010CA2428237C Process for the preparation of carbostyril derivatives
07/20/2010CA2399001C Integrin expression inhibitor
07/15/2010WO2010080253A1 Tricyclic azaindoles
07/15/2010WO2010079120A1 Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases
07/15/2010WO2010059602A3 Inhibitors of diacylglycerol acyltransferase
07/15/2010WO2010057101A3 Compounds useful as hiv blockers
07/15/2010WO2010037765A3 4 -morpholino-pyrido [3, 2 -d] pyrimidines active on pi3k
07/15/2010WO2009146034A3 Mapk/erk kinase inhibitors and methods of use thereof
07/15/2010WO2009111278A3 Raf inhibitor compounds and methods of use thereof
07/15/2010US20100179319 Process for production of optically active mirtazapine
07/15/2010US20100179304 Somatostatin-Dopamine Chimeric analogs
07/15/2010US20100179174 Substituted azaquinazolines having an antiviral action
07/15/2010US20100179173 Substituted fused pyrimidines as antagonists of gpr105 activity
07/15/2010US20100179166 Carboxamide heterocyclic cgrp receptor antagonists
07/15/2010US20100179145 Pharmaceutical combinations
07/15/2010US20100179143 Naphthyridine, derivatives as p13 kinase inhibitors
07/15/2010US20100179141 Novel jnk inhibitors
07/15/2010US20100179139 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments
07/15/2010US20100179127 Pyrimidine derivatives
07/15/2010DE202004021723U1 Medizinische Verwendung von Hemmern von Glutaminyl- und Glutamatcyclasen Medical use of inhibitors of glutaminyl and Glutamatcyclasen
07/15/2010CA2745085A1 Tricyclic azaindoles
07/14/2010EP2206715A1 Fused heterotetracyclic compounds and use thereof as hcv polymerase inhibitor
07/14/2010EP2206713A1 Beta-carbolines useful for treating inflammatory disease
07/14/2010EP2206709A2 Thiophene derivatives as antiviral agents for flavivirus infection
07/14/2010EP2206496A1 Medical use of inhibitors of glutaminyl and glutamate cyclases
07/14/2010EP2205600A1 CARBACEPHEM ß -LACTAM ANTIBIOTICS
07/14/2010EP2205599A1 Cgrp antagonists
07/14/2010EP2205598A1 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
07/14/2010EP2205592A1 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/14/2010EP2205590A1 Cgrp antagonists
07/14/2010EP2205562A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
07/14/2010EP2205558A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators
07/14/2010EP1863812B1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
07/14/2010EP1853602B1 Chemical compounds
07/14/2010EP1784188B1 Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
07/14/2010EP1648443B1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands
07/14/2010EP1636224B1 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase
07/14/2010EP1551849B1 Tricyclic tetrahydroquinoline antibacterial agents
07/14/2010CN1955179B [1,4]diazepino[6,7,1-IJ]quinoline derivatives as antipsychotic and antiobesity agents
07/14/2010CN1812789B Sulfonamide substituted imidazoquinolines
07/14/2010CN101778849A Fused quinoline derivatives useful as gaba modulators
07/14/2010CN101778848A Naphthyridine derivatives as potassium channel modulators
07/14/2010CN101778847A Crystalline pyridazine compound
07/14/2010CN101778832A oxopyrazine derivative and herbicide
07/14/2010CN101778825A N-heterocyclic compounds useful as inhibitors of janus kinases
07/14/2010CN101778651A Heterocyclic compounds for the treatment of tuberculosis
07/14/2010CN101775419A Method for extracting tsukushinamine from lespedezadavurica of leguminous plants
07/14/2010CN101775015A Synthesis method of phenanthroline-5,6-diketone
07/14/2010CN101775014A Preparation method of 5-methoxy-1H-pyrrolo(3,2-b)pyridine-1-formic acid